Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the ...
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.
Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...
Like many industries preparing for Donald Trump's second term as president, the prospects for the healthcare industry are a ...
Hawaiʻi Attorney General Anne Lopez is sending letters to more than 800 Hawaiʻi tobacco retailers and distributors about the ...
Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...
Authorities in China are investigating reports of quality problems with some drugs eligible for distribution through the ...
With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration ...
Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback